Immune to Cancer: The CRI Blog
-
CRI Funded Scientist
Kai Kun Xie, PhD
Dr. Kai Kun Xie is studying the tumor’s microenvironment. To develop effective immunotherapies for more types of… -
CRI Funded Scientist
Jing Zhang, PhD
Dr. Jing Zhang is exploring a novel cancer treatment called anti-PDL1/IL-15 (I) that aims to increase response… -
CRI Funded Scientist
Haiwei Zhang, PhD
Dr. Haiwei Zhang is exploring a groundbreaking approach to enhance immune control over colorectal tumors by disrupting… -
CRI Funded Scientist
Ahmet Bugra Tufan, PhD
Dr. Ahmet Bugra Tufan is delving into the role of factors released from cells following Gasdermin D… -
CRI Funded Scientist
Craig Haifer, PhD
Cancer immunotherapy with immune checkpoint inhibitors (ICI) has revolutionized the treatment and outcomes for multiple cancers in… -
CRI Funded Scientist
Courtney A. Matson, PhD
CD8 T cells are critical components of anti-tumor immunity through their release of cytokines and direct killing… -
CRI Funded Scientist
Marina Baretti, MD
Dr. Baretti’s project will introduce a critically needed new treatment strategy for fibrolamellar hepatocellular carcinoma (FLC) patients… -
CRI Funded Scientist
Vivek Verma, PhD
To enhance mitochondrial fitness and prevent T cell exhaustion, Dr. Verma intends to explore the possibility of… -
CRI Funded Scientist
Craig L. Slingluff, Jr., MD
Melanoma is the 5th most common cancer in the US, with almost 100,000 new diagnoses in 2022…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.